Download Our DHN Survey Result 2024
Realize your Healthcare’s Digital Transformation journey with ScaleHealthTech Learn More

Diagnostics Startup Neodocs Bags Seed Funding Led by Omidyar Network

Written by : Arti Ghargi

February 9, 2024

Category Img

The latest infusion of funds will help the startup accelerate its plans to expand in international markets, including Europe, Australia, and the Americas, among others.

IIT-Bombay-backed healthtech startup Neodocs has raised $2 million (16.6 Cr) in a seed funding round led by Omidyar Network India.

Founded in the year 2020, by three IIT-Bombay alumni - Nikunj Malpani, Anurag Meena and Pratik Lodha, the healthtech startup aims to democratise healthcare in the country.

Neodocs initially disrupted the medical landscape with two revolutionary urine-based tests: The Kidney Care Kit and the UTI Care Kit. These tests eliminated patients’ dependency on traditional lab machines.

Further, the startup also developed smartphone-based at-home test kits that enable personalised approach and ongoing progress monitoring.

(From L-R) Neodocs cofounders Anurag meena, Pratik Lodha and Nikunj Malpani

Neodocs Scaling Up Game

The latest infusion of funds will help the startup to scale up its existing kidney care and UTI care kit as well as accelerate its plans to expand in international markets, including Europe, Australia, the Middle East, the Philippines, and the Americas.

Neodocs is also developing 'instant' finger-prick blood tests that offer quick results accessible via a simple phone click—a remarkable leap in healthcare technology.

Nikunj Malpani, CEO & cofounder of Neodocs told DHN that the funds raised will help the team build R&D capabilities for the project.

Highlighting the pressing need for timely diagnosis, Malpani said, “By enabling in-clinic testing Neodocs is empowering doctors to screen and diagnose patients instantly, and start treatment immediately,” he said.

Echoing Malpani's sentiments, Aditya Misra, director, Omidyar Network India, emphasised the necessity of transitioning from reactive to preventive healthcare practices. Real-time diagnostics, he noted, stand as a cornerstone in this transition.

“We believe Neodocs’ pioneering solution can significantly expand access across income segments and geographies, enrich patient health records, and reduce cost of care to improve health outcomes,” he added.

Key Offerings from Neodocs

Neodocs platform features custom-designed test cards embedded with highly specific biochemistries, triggering visual changes such as colour or intensity alterations upon reaction completion.

With the use of a smartphone application, users can capture images of the test cards. According to the startup, its sophisticated algorithms then compensate for environmental factors like light and camera variations and provide semi-quantitative or quantitative results based on the specific test conducted.

The Kidney Risk Test, a component of Neodocs' offerings, assesses urine albumin creatinine ratio (UACR) alongside 14 other vital parameters, crucial for early detection of chronic kidney disease. In 90% of the cases, chronic kidney diseases often go undiagnosed making early detection extremely significant.

Meanwhile, the UTI Care Kit, designed to swiftly identify urinary tract infections, addresses a pressing global concern affecting 60% of women worldwide.

Shedding light on the project in the pipeline, CEO Malpani said, “The instant finger-prick blood test will be launched to test Haemoglobin levels- crucial in the detection of Anaemia, Ferritin and TSH-closely linked to hair fall, Malaria, HIV, Sickle cell anaemia, etc. So, we are coming up with a bouquet of blood tests.”

Available for online purchase, the test cards are conveniently delivered via postal services, enabling users to perform simple sampling steps and obtain results anytime, anywhere.

Additionally, Neodocs’ products have over 200,000 test cards sold and adopted by more than 4,000 doctors nationwide.

Established during the onset of the COVID-19 pandemic, the healthtech startup’s partnership goes beyond clinical settings, boasting collaborations with leading pharmaceutical giants such as Cipla, Eris, Sun Pharma, AstraZeneca, Bayer, and RPG Life Sciences.

These partnerships, coupled with governmental initiatives in Maharashtra (Nashik) and Rajasthan (Ladnu), aim to digitise testing services in remote areas, amplifying Neodocs' footprint across over 250 primary healthcare centres and sub-centers.

About Chime India

The College of Healthcare Information Management Executives (CHIME) is an executive organization dedicated to serving senior digital health leaders. CHIME includes more than 5,000 members in 56 countries and two US territories and partners with over 150 healthcare IT businesses and professional services firms. CHIME enables its members and business partners to collaborate, exchange ideas, develop professionally and advocate the effective use of information management to improve the health and care throughout the communities they serve. CHIME's members are chief information officers (CIOs), chief medical information officers (CMIOs), chief nursing information officers (CNIOs), chief innovation officers (CIOs), chief digital officers (CDOs), and other senior healthcare leaders. The CHIME India Chapter became the first international chapter outside North America in 2016 and is now a community of over 70+ members in India. For more information, please visit


Digital Health News ( DHN) is India’s first dedicated digital health news platform launched by Industry recognized HealthTech Leaders. DHN Is Industry’s Leading Source Of HealthTech Business, Insights, Trends And Policy News.

DHN Provides In-Depth Data Analysis And Covers Most Impactful News As They Happen Across Entire Ecosystem Including Emerging Technology Trends And Innovations, Digital Health Startups, Hospitals, Health Insurance, Govt. Agencies & Policies, Pharmaceuticals And Biotech.

Contact us:

© Digital Health News 2024